Published in Clin Pharmacol Ther on January 25, 2012
Pharmacogenomics and individualized medicine: translating science into practice. Clin Pharmacol Ther (2012) 2.48
Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin Genet (2012) 2.07
Pharmacogenomics in the clinic. Nature (2015) 1.71
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers. Annu Rev Pharmacol Toxicol (2014) 1.58
Personalized medicine: is it a pharmacogenetic mirage? Br J Clin Pharmacol (2012) 1.44
Personalized medicine - where do we stand? Pouring some water into wine: a realistic perspective. Croat Med J (2012) 1.35
Opportunities for genomic clinical decision support interventions. Genet Med (2013) 1.31
Pharmacogenomic knowledge gaps and educational resource needs among physicians in selected specialties. Pharmgenomics Pers Med (2014) 1.26
Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Genet Med (2016) 1.16
Pharmacogenetics in clinical practice: how far have we come and where are we going? Pharmacogenomics (2013) 1.15
Metformin pharmacogenomics: current status and future directions. Diabetes (2014) 1.15
Clinical implementation of germ line cancer pharmacogenetic variants during the next-generation sequencing era. Clin Pharmacol Ther (2013) 1.10
Pharmacogenomics in clinical practice and drug development. Nat Biotechnol (2012) 1.08
Personalizing health care: feasibility and future implications. BMC Med (2013) 1.07
Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. EMBO Rep (2014) 0.99
Scientific challenges and implementation barriers to translation of pharmacogenomics in clinical practice. ISRN Pharmacol (2013) 0.98
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting. Clin Pharmacol Ther (2015) 0.95
'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project. Per Med (2015) 0.93
Delivering pharmacogenetic testing in a primary care setting. Pharmgenomics Pers Med (2013) 0.92
Physician Attitudes toward Adopting Genome-Guided Prescribing through Clinical Decision Support. J Pers Med (2014) 0.91
An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care. PLoS One (2014) 0.91
A health-care system perspective on implementing genomic medicine: pediatric acute lymphoblastic leukemia as a paradigm. Clin Pharmacol Ther (2013) 0.91
Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians. Per Med (2012) 0.89
Pharmacogenomics of chemotherapeutic susceptibility and toxicity. Genome Med (2012) 0.89
An evaluation of pharmacogenomic information provided by five common drug information resources. J Med Libr Assoc (2014) 0.89
Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics. Front Pharmacol (2012) 0.88
Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenet Genomics (2014) 0.87
Physician response to implementation of genotype-tailored antiplatelet therapy. Clin Pharmacol Ther (2016) 0.87
Physician Awareness and Utilization of Food and Drug Administration (FDA)-Approved Labeling for Pharmacogenomic Testing Information. J Pers Med (2013) 0.86
Integrating Pharmacogenomics into Clinical Practice: Promise vs Reality. Am J Med (2016) 0.85
Clinician Perspectives on Using Pharmacogenomics in Clinical Practice. Per Med (2015) 0.84
Scenario drafting for early technology assessment of next generation sequencing in clinical oncology. BMC Cancer (2016) 0.84
Community pharmacists' attitudes towards clinical utility and ethical implications of pharmacogenetic testing. Per Med (2013) 0.82
Pharmacogenomically actionable medications in a safety net health care system. SAGE Open Med (2016) 0.81
Attitudes of clinicians following large-scale pharmacogenomics implementation. Pharmacogenomics J (2015) 0.81
How can psychological science inform research about genetic counseling for clinical genomic sequencing? J Genet Couns (2014) 0.81
Striking a balance in communicating pharmacogenetic test results: promoting comprehension and minimizing adverse psychological and behavioral response. Patient Educ Couns (2014) 0.80
Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics. Pharmgenomics Pers Med (2016) 0.80
Ethical, legal and social implications of incorporating personalized medicine into healthcare. Per Med (2015) 0.80
Effects of Using Personal Genotype Data on Student Learning and Attitudes in a Pharmacogenomics Course. Am J Pharm Educ (2016) 0.79
Using systems approaches to address challenges for clinical implementation of pharmacogenomics. Wiley Interdiscip Rev Syst Biol Med (2013) 0.79
Implementation of a clinical research pharmacogenomics program at an academic medical center: role of the genetics healthcare professional. Pharmacogenomics (2013) 0.79
Personalized medicine and genetic malpractice. Genet Med (2013) 0.78
Pharmacogenomics in diverse practice settings: implementation beyond major metropolitan areas. Pharmacogenomics (2015) 0.78
Multidisciplinary model to implement pharmacogenomics at the point of care. Genet Med (2016) 0.78
A survey of physician receptivity to molecular diagnostic testing and readiness to act on results for early-stage colon cancer patients. BMC Cancer (2016) 0.78
Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine. Pharmacogenet Genomics (2014) 0.77
Differences in Weight Loss Between Persons on Standard Balanced vs Nutrigenetic Diets in a Randomized Controlled Trial. Clin Gastroenterol Hepatol (2015) 0.77
Challenges to integrating pharmacogenetic testing into medication therapy management. J Manag Care Spec Pharm (2015) 0.77
Pharmacogenomic testing: knowing more, doing better. Clin Pharmacol Ther (2012) 0.77
Personalized Medicine in the U.S. and Germany: Awareness, Acceptance, Use and Preconditions for the Wide Implementation into the Medical Standard. J Pers Med (2016) 0.76
Do physicians think genomic medicine will be useful for patient care? Per Med (2015) 0.76
Practical considerations for implementing genomic information resources. Experiences from eMERGE and CSER. Appl Clin Inform (2016) 0.75
Pharmacogenomics competencies in pharmacy practice: A blueprint for change. J Am Pharm Assoc (2003) (2016) 0.75
A review of consent practices and perspectives for pharmacogenetic testing. Pharmacogenomics (2016) 0.75
Cancer pharmacogenomics, challenges in implementation, and patient-focused perspectives. Pharmgenomics Pers Med (2016) 0.75
Medical student preparedness for an era of personalized medicine: findings from one US medical school. Per Med (2016) 0.75
"Getting off the Bus Closer to Your Destination": Patients' Views about Pharmacogenetic Testing. Perm J (2015) 0.75
Contrasting Medical and Legal Standards of Evidence: A Precision Medicine Case Study. J Law Med Ethics (2016) 0.75
Diffusion of molecular diagnostic lung cancer tests: a survey of german oncologists. J Pers Med (2014) 0.75
An inter-professional approach to personalized medicine education: one institution's experience. Per Med (2015) 0.75
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require? Pharm Res (2017) 0.75
Characterizing pharmacogenomic-guided medication use with a clinical data repository. Clin Pharmacol Ther (2017) 0.75
"The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems". Clin Pharmacol Ther (2017) 0.75
Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). Eur J Clin Pharmacol (2017) 0.75
Physicians' pharmacogenomics information needs and seeking behavior: a study with case vignettes. BMC Med Inform Decis Mak (2017) 0.75
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing. Clin Pharmacol Ther (2017) 0.75
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care (1998) 24.53
Difficult Airway Society Guidelines for the management of tracheal extubation. Anaesthesia (2012) 7.19
Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med (1991) 5.83
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax (1992) 5.37
Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys (1999) 4.72
The frequency of uterine leiomyomas. Am J Clin Pathol (1990) 4.00
ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol (2001) 3.55
Randomized clinical trial of early laparoscopy in the management of acute non-specific abdominal pain. Br J Surg (1999) 3.18
Interpretation of quality of life changes. Qual Life Res (1993) 3.06
A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care (1995) 2.99
Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes Care (1998) 2.88
Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care (1997) 2.69
Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health (1997) 2.68
Lyme arthritis in the Hunter Valley. Med J Aust (1982) 2.68
Microscopic satellitosis in patients with primary cutaneous melanoma: implications for nodal basin staging. Ann Surg Oncol (2009) 2.67
Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. Int J Epidemiol (2003) 2.57
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Using Medicare claims for outcomes research. Med Care (1994) 2.46
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia (2011) 2.28
Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources. Proc Natl Acad Sci U S A (1985) 2.26
Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health (2007) 2.25
Fewer sore throats and a better seal: why routine manometry for laryngeal mask airways must become the standard of care. Anaesthesia (2014) 2.21
A randomised controlled trial of cognitive behaviour therapy and motivational interviewing for people with Type 1 diabetes mellitus with persistent sub-optimal glycaemic control: a Diabetes and Psychological Therapies (ADaPT) study. Health Technol Assess (2010) 2.20
Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia (2003) 2.18
Smoking, quitting, and the risk of cardiovascular disease among women and men in the Asia-Pacific region. Int J Epidemiol (2005) 2.16
Microdeletion 15q13.3: a locus with incomplete penetrance for autism, mental retardation, and psychiatric disorders. J Med Genet (2009) 2.13
An office on Main Street. Health care dilemmas in small communities. Hastings Cent Rep (1999) 2.05
Neutral-lipid storage disease: a new disorder of lipid metabolism. Br Med J (1975) 1.97
Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science (1991) 1.93
A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation (1995) 1.90
Mixed glioneuronal tumour of the fourth ventricle with prominent rosette formation. Neuropathol Appl Neurobiol (2006) 1.88
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science (1992) 1.85
Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum (1993) 1.80
Vertebral fracture prevalence in women in Hiroshima compared to Caucasians or Japanese in the US. Int J Epidemiol (1995) 1.76
Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology (1995) 1.73
Speed of onset of 'corner pocket supraclavicular' and infraclavicular ultrasound guided brachial plexus block: a randomised observer-blinded comparison. Anaesthesia (2009) 1.71
What information enables a listener to map a talker's vowel space? J Acoust Soc Am (1976) 1.70
Biochemical basis for fluorouracil neurotoxicity. The role of Krebs cycle inhibition by fluoroacetate. Arch Neurol (1970) 1.64
Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J Exp Med (1995) 1.63
Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med (1998) 1.61
Hospital utilization patterns and costs for adult sickle cell patients in Illinois. Public Health Rep (1997) 1.60
Improved toluidine blue-DNA agar for detection of DNA hydrolysis by campylobacters. J Clin Microbiol (1987) 1.59
Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial. Diabetologia (2009) 1.59
The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion (2009) 1.57
Transtracheal jet ventilation in 50 patients with severe airway compromise and stridor. Br J Anaesth (2010) 1.56
A bacterial basic region leucine zipper histidine kinase regulating toluene degradation. Proc Natl Acad Sci U S A (1997) 1.55
Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am J Vet Res (1998) 1.55
Localization of impalpable breast lesions--a surgical approach. Eur J Surg Oncol (1996) 1.54
A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate. Ann Rheum Dis (2004) 1.53
Use of antibiotic prophylaxis in elective inguinal hernia repair in adults in London and south-east England: a cross-sectional survey. Hernia (2013) 1.50
Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum (2000) 1.50
22q13.3 deletion syndrome: clinical and molecular analysis using array CGH. Am J Med Genet A (2010) 1.49
Ultrasound detection of extrahepatic encapsulated bile: "biloma". AJR Am J Roentgenol (1979) 1.48
Effects of flooding amino acids on incorporation of labeled amino acids into human muscle protein. Am J Physiol (1998) 1.47
Mice lacking transforming growth factor alpha have an increased susceptibility to dextran sulfate-induced colitis. Gastroenterology (1997) 1.46
Bilateral iridocorneal endothelial syndrome: case report and review of the literature. Cornea (1994) 1.45
Comparison of percent free PSA, PSA density, and age-specific PSA cutoffs for prostate cancer detection and staging. Urology (2000) 1.44
Furosemide-albumin complexes in refractory nephrotic syndrome and chronic renal failure. Nephron (1996) 1.42
Pollination mode in fig wasps: the predictive power of correlated traits. Proc Biol Sci (2001) 1.41
Cutaneous leishmaniasis in Multan, Pakistan. Int J Dermatol (1998) 1.41
The immunogenicity, safety, and efficacy of etanercept liquid administered once weekly in patients with rheumatoid arthritis. Clin Exp Rheumatol (2007) 1.41
Polycystic ovaries in patients with hypogonadotropic hypogonadism: similarity of ovarian response to gonadotropin stimulation in patients with polycystic ovarian syndrome. Fertil Steril (1992) 1.40
The effect of temperature on bougies: a photographic and manikin study. Anaesthesia (2008) 1.40
Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. J Clin Endocrinol Metab (1990) 1.40
Intra-operative frozen section analysis for suspected early-stage ovarian cancer: 11 years of Gateshead Cancer Centre experience. BJOG (2011) 1.39
Calcium and extrapyramidal symptoms. Br J Psychiatry (1988) 1.38
Consonant environment specifies vowel identity. J Acoust Soc Am (1976) 1.37
Protective effect of epidermal growth factor in an experimental model of colitis in rats. Gastroenterology (1994) 1.37
Bronchodilator delivery in acute airflow obstruction. A meta-analysis. Arch Intern Med (1997) 1.37
Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes. Heart (2007) 1.36
Predictors of ovarian reserve in young women with breast cancer. Br J Cancer (2007) 1.35
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther (2010) 1.35
Clinical effectiveness of a rehabilitation program integrating exercise, self-management, and active coping strategies for chronic knee pain: a cluster randomized trial. Arthritis Rheum (2007) 1.34
Feline acromegaly: an underdiagnosed endocrinopathy? J Vet Intern Med (2007) 1.33
Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. J Infect Dis (1999) 1.32
Microdeletions including YWHAE in the Miller-Dieker syndrome region on chromosome 17p13.3 result in facial dysmorphisms, growth restriction, and cognitive impairment. J Med Genet (2009) 1.31
Intensity of vascular endothelial growth factor expression is associated with increased risk of recurrence and decreased disease-free survival in papillary thyroid cancer. Surgery (2001) 1.29
Acute and chronic posttraumatic stress disorder in motor vehicle accident victims. Am J Psychiatry (1999) 1.29
The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care (1995) 1.28
Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis. Diabetes (1999) 1.26
Spontaneous regression of human melanoma/nonmelanoma skin cancer: association with infiltrating CD4+ T cells. World J Surg (1995) 1.26
Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review. Am J Med Genet A (2007) 1.26
Comparison of latex agglutination and immunofluorescence for direct Lancefield grouping of streptococci from blood cultures. J Clin Microbiol (1984) 1.25
Gender differences in posttraumatic stress disorder after motor vehicle accidents. Am J Psychiatry (2001) 1.25
Systolic blood pressure, diabetes and the risk of cardiovascular diseases in the Asia-Pacific region. J Hypertens (2007) 1.25
Characterization of idiopathic premature ovarian failure. Fertil Steril (1996) 1.24
ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric-oxide synthase gene. J Biol Chem (2000) 1.24
Gum arabic glycoprotein contains glycomodules of both extensin and arabinogalactan-glycoproteins. Phytochemistry (2000) 1.23
Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial. Am J Clin Nutr (1999) 1.22
A potential novel marker for human prostate cancer: voltage-gated sodium channel expression in vivo. Prostate Cancer Prostatic Dis (2005) 1.22
Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth (2002) 1.21
Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart (2003) 1.21
Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum (1997) 1.21
Estimating the population incidence of adult post-intubation laryngotracheal stenosis. Clin Otolaryngol (2007) 1.18